This is the authors' abstract. We don't add key points for this paper.
Finally, we suggest that gingerenone-A and shogaol may either be potential SaHPPK inhibitors or can be used as fundamental platforms for novel SaHPPK inhibitor development.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Rampogu et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: